[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349884-105":59,"doc-detail-349884-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","variant-reclassification-in-cancer-susceptibility-genes-and-an-updated-variant-spectrum-of-turkish-breast-and-colorectal-cancer-patients","Variant reclassification in cancer susceptibility genes and an updated variant spectrum of Turkish breast and colorectal cancer patients","","Multigene panel testing (MGPT) identifies pathogenic variants behind hereditary cancers, but interpreting variants of uncertain significance (VUS) remains difficult, especially in populations underrepresented in population genomic databases. This study analyzed 25 cancer susceptibility genes in a Turkish cohort of 1293 breast cancer, 370 colorectal cancer, and 914 cancer-free controls. Re-evaluation of 415 previously reported VUS led to reclassification of 98 as benign and 16 as pathogenic variants, raising positive test rates and reducing inconclusive results. Overall, it supports case–control design for population-specific variant interpretation, improving clinical utility of MGPT.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/variant-reclassification-in-cancer-susceptibility-genes-and-an-updated-variant-spectrum-of-turkish-breast-and-colorectal-cancer-patients/349884/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/variant-reclassification-in-cancer-susceptibility-genes-and-an-updated-variant-spectrum-of-turkish-breast-and-colorectal-cancer-patients/349884.png","ImageObject",300,407,{"name":92,"@type":93},"Levi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What problem does the study address regarding multigene panel testing?","Question",{"text":113,"@type":114},"It focuses on the challenge of clinically interpreting variants of uncertain significance (VUS), especially for populations underrepresented in population genomic databases.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was the Turkish cohort analyzed in this research?",{"text":118,"@type":114},"The study analyzed 25 cancer susceptibility genes in 1293 breast cancer patients, 370 colorectal cancer patients, and 914 cancer-free controls.",{"name":120,"@type":111,"acceptedAnswer":121},"What was the impact of reclassifying previously reported VUS?",{"text":122,"@type":114},"Reclassification converted 98 VUS to benign and 16 VUS to pathogenic variants, increasing positive test rates in both breast and colorectal cancer groups and reducing inconclusive results overall.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},349884,1790516702,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Can etal. Human Genomics (2026) 20:39 Human Genomics  \n[https://doi.org/10.1186/s40246-026-00915-0](https://doi.org/10.1186/s40246-026-00915-0)  \nRESEARCH Open Access  \nVariant reclassification in cancer susceptibility genes and an updated variant spectrum of Turkish breast and colorectal cancer patients  \nNisan Denizce Can1, Izzet Mehmet Akcay2, Elifnaz Celik3,4, Ceren Ciftci1, Busra Unal5, Nihat Bugra Agaoglu5,6, Hamdi Levent Doganay7,8 and Gizem Dinler Doganay1*  \nAbstract  \nMultigene panel testing (MGPT) is a powerful tool for identifying pathogenic variants (PVs) underlying hereditary cancers. However, the clinical interpretation of variants of uncertain significance (VUS) remains a major challenge, particularly in populations underrepresented in population genomic databases. In this study, we analyzed 25 cancer susceptibility genes in a Turkish cohort comprising 1293 breast cancer (BC) patients, 370 colorectal cancer (CRC) patients, and 914 cancer-free controls. Compared with our previous work, the expanded dataset enabled a more refined classification of germline variants. In total, we identified 217 distinct PVs and 494 distinct VUS. Among BC patients, PVs were enriched in BRCA1, BRCA2, PALB2, CHEK2, and ATM, while in CRC patients PVs were enriched in MLH1, MUTYH, MSH2, and CHEK2 . Notably, CHEK2 was among the most frequently mutated genes, and harbored the highest number of distinct PVs and VUS per coding region. Given the underrepresentation of the Turkish population in public variant databases and the continuous accumulation of population and functional evidence, we systematically re-evaluated the 415 VUS reported 5 years ago in the initial freeze of this cohort. This reclassification resulted in 98 VUS being reclassified as benign and 16 as PVs, increasing positive test rates by 3. 7% in BC patients and 1. 6% in CRC patients, while reducing inconclusive results by approximately 9% across all study groups. Overall, this study underscores the importance of case–control design for population-specific variant interpretation and demonstrates how systematic reclassification can substantially enhance the clinical utility of MGPT. The findings contribute to improving hereditary cancer risk prediction in the Turkish population and have important implications for the development of future variant reclassification frameworks.  \nKeywords Breast cancer, Colorectal cancer, Hereditary cancer predisposition, Multigene panel testing, Variant reclassification  \n*Correspondence: Gizem Dinler Doganay[gddoganay@itu.edu.tr](gddoganay@itu.edu.tr)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nCan et al. Human Genomics (2026) 20:39  \nIntroduction  \nHereditary cancers arise from germline pathogenic variants (PVs) in cancer susceptibility genes and are often characterized by a relatively e","cbCaigw6E4pXG8oO","https://ap.wps.com/l/cbCaigw6E4pXG8oO","pdf",2623783,"English","# Abstract\n# Introduction","[{\"question\":\"What problem does the study address regarding multigene panel testing?\",\"answer\":\"It focuses on the challenge of clinically interpreting variants of uncertain significance (VUS), especially for populations underrepresented in population genomic databases.\"},{\"question\":\"How was the Turkish cohort analyzed in this research?\",\"answer\":\"The study analyzed 25 cancer susceptibility genes in 1293 breast cancer patients, 370 colorectal cancer patients, and 914 cancer-free controls.\"},{\"question\":\"What was the impact of reclassifying previously reported VUS?\",\"answer\":\"Reclassification converted 98 VUS to benign and 16 VUS to pathogenic variants, increasing positive test rates in both breast and colorectal cancer groups and reducing inconclusive results overall.\"}]","Variant reclassification in cancer susceptibility genes and an updated variant spectrum of Turkish breast and colorectal cancer patients | PDF",1790086074,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/83c16a47dd936968211f7d066a92be7b.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2a4a31983bd4513f426956baea62395a.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b1e2979cf88e863fbc2d3c6ccdc30453.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f12cc5b4da7202de5d48b4ba449bf18b.webp",980,1306]